Expanesthetics has embraced its mission to usher in the next generation of inhaled anesthetics and non-opioid analgesics by gathering a world-class team of scientific and clinical advisors, directors, industry partners, and executives, along with anesthesiologist and other investors. To all of our colleagues in the anesthesia field, and to everyone who wants to play a part in the future of inhaled anesthesia, we'd like to invite you to be a part of it.
There is a saying in the world of investing that has guided many to success:
"Invest in what you know."
- Attributed to Peter Lynch1
In Expanesthetics' case, the investors who best understand our technology and our market are anesthesia clinicians. Many have already joined us.
We are raising up to $15 million from you and your colleagues toward developing new general anesthetics and non-opioid analgesics. Dozens of anesthesia providers have already joined in along with many others.2 You can, too.3
To learn more details about this investment opportunity, please fill out the registration form on this page. You will then get an activation link via email. When you return, you will have the chance to sign a non-disclosure agreement that will give you access to confidential information you can use to help you make your investment decision.
1 Former manager of Fidelity's Magellan Fund between 1977 and 1990 where he averaged an annual return of almost 30%.
2 As of May 10, Expanesthetics has approximately 92 investors including dozens of anesthesiologists. Others include dentists, biotech executives, hospital executives, and professional investors.
3 This is not an offer to sell or a solicitation of any offer to buy any securities. Offers are made only by prospectus or other offering materials. Only prospective investors who have been invited to review such materials and meet the suitability standards required by law are eligible to invest. This document includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Expanesthetics' management and are subject to significant risks and uncertainties. There can be no guarantees. These statements are made as of the date of this communication and Expanesthetics assumes no obligation to provide updates.